Quality of life in young patients after cone reconstruction for Ebstein anomaly.


Journal

Cardiology in the young
ISSN: 1467-1107
Titre abrégé: Cardiol Young
Pays: England
ID NLM: 9200019

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 15 6 2019
medline: 7 1 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

To evaluate the health status and quality of life of young patients who had cone reconstruction for Ebstein anomaly. We reviewed all patients who had cone reconstruction from 2007 to 2016 at our institution. Prospective surveys were mailed to all eligible patients. Quality of life was assessed using the PedsQL 4.0 Generic Core Scales, including four domains: physical, emotional, social, and school functioning. Of 116 eligible patients, 72 (62%) responded. About 96% reported their health as excellent or good, and 52% were symptom-free. Only 37% of patients were taking any medications, the most common of which was aspirin (30%). Only 19% had been hospitalised for cardiac reasons following cone reconstruction. The average self-reported quality of life was 85.3/100, whereas the average parent proxy-reported quality of life was 81.8/100. There was no difference by self or parent proxy-report in quality of life between cone reconstruction patients and healthy children; however, quality of life was significantly better compared with children with other chronic health conditions. By self-report and parent proxy-report, 15.1 and 16.7% of patients were deemed "at risk" for reduced quality of life, respectively. Socially, 63/64 (98%) patients over 5 years old were either full-time students or working full-time. Children with Ebstein anomaly following cone reconstruction have excellent quality of life comparable with healthy peers and significantly better than other children with chronic health conditions. Families of children with Ebstein anomaly can expect excellent quality of life, long-term health status, and social functioning following cone reconstruction.

Identifiants

pubmed: 31198119
pii: S1047951119000726
doi: 10.1017/S1047951119000726
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

756-760

Auteurs

Kristen L Sessions (KL)

School of Medicine, Mayo Clinic,Rochester, MN,USA.

Charlotte Van Dorn (C)

Division of Pediatric Cardiology,Mayo Clinic,Rochester, MN,USA.

Joseph A Dearani (JA)

Department of Cardiothoracic Surgery,Mayo Clinic,Rochester, MN,USA.

Simrit Warring (S)

School of Medicine, Mayo Clinic,Rochester, MN,USA.

Kaitlin Leopold (K)

School of Medicine, Mayo Clinic,Rochester, MN,USA.

Philip L Wackel (PL)

Division of Pediatric Cardiology,Mayo Clinic,Rochester, MN,USA.

Frank Cetta (F)

Division of Pediatric Cardiology,Mayo Clinic,Rochester, MN,USA.

Jonathan N Johnson (JN)

Division of Pediatric Cardiology,Mayo Clinic,Rochester, MN,USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH